WVE

Wave Life Sciences, Inc. - Common Stock (WVE)

About Wave Life Sciences, Inc. - Common Stock (WVE)

Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.

Details

Daily high

$3.88

Daily low

$3.70

Price at open

$3.81

52 Week High

$21.73

52 Week Low

$3.56

Market cap

744.8M

Dividend yield

Volume

2.0M

Avg. volume

3.3M

P/E ratio

-3.48

Wave Life Sciences, Inc. - Common Stock News